Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine
Status:
Completed
Trial end date:
2021-01-09
Target enrollment:
Participant gender:
Summary
This is a double blind, placebo controlled study in approximately 2,000 health care workers
at risk for being exposed to COVID-19. Eligible participants will be randomly assigned (1:1)
to either treatment group (HCQ) or placebo in a double-blind fashion. Course of treatment is
30 days.